When.com Web Search

Search results

1. Results From The WOW.Com Content Network

2. List of COVID-19 vaccine authorizations - Wikipedia

   en.wikipedia.org/wiki/List_of_COVID-19_vaccine...

   National regulatory authorities have granted full or emergency use authorizations for 40 COVID-19 vaccines.. Ten vaccines have been approved for emergency or full use by at least one stringent regulatory authority recognized by the World Health Organization (WHO): Pfizer–BioNTech, Oxford–AstraZeneca, Sinopharm BIBP, Moderna, Janssen, CoronaVac, Covaxin, Novavax, Convidecia, and Sanofi ...

3. COVID-19 vaccine clinical research - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccine_clinical...

   COVID-19 vaccine clinical research uses clinical research to establish the characteristics of COVID-19 vaccines. These characteristics include efficacy , effectiveness , and safety. As of November 2022 [update] , 40 vaccines are authorized by at least one national regulatory authority for public use: [ 1 ] [ 2 ]

4. Gilead's (GILD) CAR T Cell Therapy Yescarta Gets FDA ... - AOL

   www.aol.com/news/gileads-gild-car-t-cell...

   For premium support please call: 800-290-4726 more ways to reach us

5. COVID-19 vaccination in the United States - Wikipedia

   en.wikipedia.org/wiki/COVID-19_vaccination_in...

   The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States.The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [7] and mass vaccinations began four days later.

6. Gilead’s Kite Receives FDA Approval For Yescarta ... - AOL

   www.aol.com/news/gilead-kite-receives-fda...

   The Gilead (GILD) company said that the US regulator’s decision was based on ZUMA-5, a single-arm, open-label study, that demonstrated 91% of patients with relapsed or refractory FL (n=81 ...

7. US FDA advisers to consider if new COVID shots should ... - AOL

   www.aol.com/news/covid-shots-target-jn-1...

   The FDA staff's review for updating viral strains for vaccines in the U.S. differs from that of the World Health Organization's advisers, who in April recommended targeting only the JN.1 strain.